New jobs are in the pipeline after a Manor Royal firm secured an £80million contract to provide equipment to two cancer centres.
Varian Medical, a world leader in radiotherapy systems and software, was selected to equip and service the national proton therapy centres which are to be built in London and Manchester.
A Varian spokesman said the news had left staff at the Gatwick Road company “very excited”.
Chief executive officer Dow Wilson added: “Varian is proud to have been selected as the preferred equipment supplier for these new proton therapy facilities.
“As the leading supplier of radiotherapy equipment and software to the National Health Service, we will be able to leverage our existing UK-based engineering and logistics infrastructure to deliver industry leading technology while meeting the NHS requirements for value for money.”
Proton therapy – known as ProBeam – makes it possible to treat certain types of cancer more precisely and with potentially fewer side effects than with conventional radiation therapy.
The beam deposits its dose directly into the tumor site rather than passing all the way through the patient.
Varian, which also has contracts for system installations at eight other sites around the world, was chosen for the new projects after the contract was put out to public tender.
Mr Wilson added: “This major project will result in a number of additional highly-skilled engineering jobs and an expansion of our UK organisation, which currently includes both manufacturing and support.”
The new centres will be built at University College London Hospitals NHS Foundation Trust and The Christie NHS Foundation Trust in Manchester.
The equipment installation is expected to take place from August 2017, with patient treatments expected to begin from 2018.